CURIA SPAIN SAU

Overview

CURIA SPAIN SAU is an active pharmaceutical ingredient (API) supplier with 43 active FDA Type II Drug Master Files, covering ALCAFTADINE; ALCLOMETASONE DIPROPIONATE; ALTRENOGEST; BETAMETHASONE DIPROPIONATE; BETAMETHASONE SODIUM PHOSPHATE; BREXANOLONE.

API / Drug Master Files

CURIA SPAIN SAU holds 43 active (43 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• GANAXOLONEActive2026-03-03
• METHYLPREDNISOLONE HEMISUCCINATEActive2025-09-17
• DEUCRAVACITINIBActive2025-03-28
• VILOXAZINE HYDROCHLORIDEActive2024-04-12
• BETAMETHASONE SODIUM PHOSPHATEActive2023-09-20
• HYDROCORTISONE HEMISUCCINATE MICRONIZED AND NON-MICRONIZEDActive2023-09-18
• FLUTICASONE PROPIONATE MICRONIZEDActive2022-09-15
• MIFEPRISTONE MICRONIZEDActive2022-06-28
• UPADACITINIBActive2022-06-01
• VOXELOTORActive2022-03-30
• FLUOROMETHOLONE MICRONIZEDActive2022-02-08
• HYDROCORTISONE SODIUM PHOSPHATEActive2021-06-01
• BREXANOLONEActive2020-04-24
• CORTEXOLONE 17a PROPIONATEActive2019-06-10
• DEOXYCHOLIC ACIDActive2019-01-16

Showing 15 of 43 Drug Master Files.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to CURIA SPAIN SAU in our records. PharmaTek screens the full directory against live FDA enforcement data.